Home
Atea Pharmaceuticals AVIR filed Q3 2023 lobbying · under $5,000 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- Under $5,000
- Quarter
- Q3 2023
- Client
- Atea Pharmaceuticals
- Reported
- 23/11/14
$240K on lobbying this year
What else happened in Atea Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 23/08/31~23/10/30Atea Pharmaceuticals's other lobbying reports
- Atea Pharmaceuticals
LobbyingAtea Pharmaceuticals
LobbyingAtea Pharmaceuticals
AVIR
$10K
$10K
Reported 07/20
for Q2
- Atea Pharmaceuticals
LobbyingAtea Pharmaceuticals
LobbyingAtea Pharmaceuticals
AVIR
$10K
$10K
Reported 04/20
for Q1
- Atea Pharmaceuticals
LobbyingAtea Pharmaceuticals
LobbyingAtea Pharmaceuticals
AVIR
$10K
$10K
Reported 01/20
for Q4 2025
- Atea Pharmaceuticals
LobbyingAtea Pharmaceuticals
LobbyingAtea Pharmaceuticals
AVIR
$10K
$10K
Reported 25/10/20
for Q3 2025
- Atea Pharmaceuticals
LobbyingAtea Pharmaceuticals
LobbyingAtea Pharmaceuticals
AVIR
Under $5,000
Under $5,000
Reported 24/10/20
for Q3 2024